PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Vaccination (9 February 2021)

Public Heath England’s surveillance strategy monitor how effective the vaccine is at protecting against a range of outcomes, including infection, symptomatic disease, hospitalisations, mortality, and onwards transmission. The surveillance strategy is available at the following link:

https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-strategy

The National Institute for Health Research (NIHR) and the UK Research and Innovation are jointly funding the UK Coronavirus Immunology Consortium to address key questions around the immune system’s response to COVID-19. The NIHR’s Health Protection Research Unit in Respiratory Infections is also looking at the size and longevity of the immune response.